<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01121055</url>
  </required_header>
  <id_info>
    <org_study_id>Lorazepam in FB</org_study_id>
    <nct_id>NCT01121055</nct_id>
  </id_info>
  <brief_title>Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy</brief_title>
  <official_title>Effect of Additive Lorazepam on Patient Satisfaction as a Premedication in Diagnostic Flexible Bronchoscopy</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Seoul National University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Seoul National University Hospital</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Many patients undergoing flexible bronchoscopy (FB) experience anxiety and discomfort during
      the procedure. The investigators want to evaluate whether an additional Lorazepam
      premedication would improve patient satisfaction for FB.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The enrolled patients are randomized to either the control or Lorazepam groups according to a
      random sample chart of numbers. The patients complete questionnaires about baseline anxiety
      level and satisfaction for FB within 24 hours after the FB.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>March 2010</start_date>
  <completion_date type="Anticipated">December 2010</completion_date>
  <primary_completion_date type="Anticipated">August 2010</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>patient satisfaction</measure>
    <time_frame>within 24 hr of bronchoscopy</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>relationship between patient satisfaction and sleep quality, anxiety level</measure>
    <time_frame>24hr before and after bronchoscopy</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">372</enrollment>
  <condition>Patient Satisfaction for Bronchoscopy</condition>
  <arm_group>
    <arm_group_label>Control</arm_group_label>
    <arm_group_type>Placebo Comparator</arm_group_type>
    <description>Placebo 1T by mouth (po) at night one day before FB and placebo 1T po 30min before the FB</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Lorazepam</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Lorazepam 0.5mg po at night one day before FB and Lorazepam 1mg po 30min before the FB</description>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Lorazepam</intervention_name>
    <description>Lorazepam 0.5mg po at night one day before FB and Lorazepam 1mg po 30min before the FB</description>
    <arm_group_label>Lorazepam</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Control</intervention_name>
    <description>Placebo 1T po at night one day before FB and placebo 1T po 30min before the FB</description>
    <arm_group_label>Control</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Adult patients (aged 18 years or older) admitted to the Respiratory Department

        Exclusion Criteria:

          -  outpatient procedures

          -  therapeutic bronchoscopy

          -  expected operation or discharge within 24 hours after the FB

          -  sedative premedication

          -  endotracheal intubation with mechanical ventilation

          -  inability to speak Korean
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Seok-Chul Yang, MD</last_name>
    <role>Study Chair</role>
    <affiliation>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Seok-Chul Yang, MD, PhD</last_name>
    <phone>+82-2-2072-0354</phone>
    <email>scyang@snu.ac.kr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Jong Sun Park, MD</last_name>
    <email>jspark.im@gmail.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Seoul National University Hospital</name>
      <address>
        <city>Seoul</city>
        <zip>110-744</zip>
        <country>Korea, Republic of</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Seok-Chul Yang, MD</last_name>
      <email>scyang@snu.ac.kr</email>
    </contact>
    <contact_backup>
      <last_name>Jong Sun Park, MD</last_name>
      <email>jspark.im@gmail.com</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Korea, Republic of</country>
  </location_countries>
  <verification_date>May 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 9, 2010</study_first_submitted>
  <study_first_submitted_qc>May 9, 2010</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2010</study_first_posted>
  <last_update_submitted>May 27, 2010</last_update_submitted>
  <last_update_submitted_qc>May 27, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 31, 2010</last_update_posted>
  <responsible_party>
    <name_title>Seok-Chul Yang, MD, PhD, FCCP</name_title>
    <organization>Division of Pulmonology and Critical Care Medicine, Department of Internal Medicine and Lung Institute of Medical Research Center, Seoul National University College of Medicine</organization>
  </responsible_party>
  <keyword>Fiberoptic Bronchoscopy</keyword>
  <keyword>Patient</keyword>
  <keyword>Satisfaction</keyword>
  <keyword>Lorazepam</keyword>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Lorazepam</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

